Suppr超能文献

一种新型膜结合OprI脂蛋白表达载体。革兰氏阴性菌中异源融合蛋白的高效表达及其在口服疫苗接种中的意义。

A new membrane-bound OprI lipoprotein expression vector. High production of heterologous fusion proteins in gram (-) bacteria and the implications for oral vaccination.

作者信息

Cote-Sierra J, Jongert E, Bredan A, Gautam D C, Parkhouse M, Cornelis P, De Baetselier P, Revets H

机构信息

Department of Immunology, Parasitology and Ultrastructure, Flanders Interuniversity Institute for Biotechnology, Vrije Universiteit Brussel, Sint Genesius Rode, Belgium.

出版信息

Gene. 1998 Oct 9;221(1):25-34. doi: 10.1016/s0378-1119(98)00437-5.

Abstract

We have previously described the development of cloning vectors for the production of OprI-based outer membrane fusion proteins in E. coli (Cornelis et al., 1996) and now describe the construction of a new vector, containing a lacI(q) gene, resulting in tight repression of the promotor and allowing its use in other Gram (-) bacteria. The new pVUB3 expression vector encodes a truncated but active LacI(q)(341) repressor which binds to the single operator in the vector. A high repression of the trc promotor was observed, resulting in a very low basal leakage of expression and very high production levels of OprI or derivatives after IPTG induction in E. coli. Bacterial viability was not affected under uninduced conditions, but the number of viable cell counts decreased after production of large amounts of the outer membrane-bound OprI lipoprotein and its derivatives, both in E. coli and Salmonella typhimurium. This highly repressible system allows us to extend the use of OprI vectors in other Gram (-) bacteria, resulting in the production of outer membrane-bound lipid-modified molecules, opening the possibility for its application in the design of potential live Salmonella-based subunit vaccines.

摘要

我们之前描述了用于在大肠杆菌中生产基于OprI的外膜融合蛋白的克隆载体的开发(Cornelis等人,1996年),现在描述一种新载体的构建,该载体含有lacI(q)基因,可导致启动子的紧密抑制,并允许其用于其他革兰氏阴性菌。新的pVUB3表达载体编码截短但有活性的LacI(q)(341)阻遏蛋白,它与载体中的单个操纵子结合。观察到trc启动子受到高度抑制,导致表达的基础渗漏非常低,并且在大肠杆菌中用IPTG诱导后,OprI或其衍生物的产量非常高。在未诱导条件下细菌活力不受影响,但在大肠杆菌和鼠伤寒沙门氏菌中大量产生外膜结合的OprI脂蛋白及其衍生物后,活细胞计数数量减少。这种高度可抑制的系统使我们能够将OprI载体的使用扩展到其他革兰氏阴性菌中,从而生产外膜结合的脂质修饰分子,为其在潜在的基于沙门氏菌的亚单位疫苗设计中的应用开辟了可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验